Treatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings.
AuthorsO'Brien, D P
AffiliationAIDS Working Group, Médecins Sans Frontières, Paris, France. email@example.com
MetadataShow full item record
JournalClinical Infectious Diseases
AbstractA study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.
- Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
- Authors: Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A
- Issue date: 2008 Jul 11
- In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
- Authors: O'Brien DP, Sauvageot D, Zachariah R, Humblet P, Medecins Sans Frontieres.
- Issue date: 2006 Oct 3
- Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
- Authors: Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, Joffres M, Anema A, Cooper CL, Montaner JS, Mills EJ
- Issue date: 2008 Nov 30
- Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.
- Authors: Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A, Academic Alliance for AIDS Care and Prevention in Africa.
- Issue date: 2007 Oct 1
- Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
- Authors: Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG, Pediatric AIDS Clinical Trials Group P1030 Team.
- Issue date: 2007 May 15